6Jamora MJ,Jiao D,Bystryn JC.Antibodies to desmoglein 1 and 3,and the clinical phenotype of pemphigus vulgaris. Journal of the American Academy of Dermatology . 2003
7Harman KE,Gratian MJ,Shirlaw PJ,et al.The transition of pem-phigus vulgaris into pemphigus foliaceus:a reflection of chang-ing desmoglein1and3autoantibody levels in pemphigus vulgar-is. Br J Dermatol . 2002
8Salmanpour R,Shahkar H,Namazi MR,et al.Epidemiology of pemphigus in south-western Iran:a10-year retrospective study(1991-2000). International Journal of Dermatology . 2006
9Scully C,Paes De Almeida O,Porter SR,et al.Pemphigus vul-garis:the manifestations and long-term management of55pa-tients with oral lesions. Br J Dermatol . 1999
10Arin MJ,Engert A,Krieg T,et al.Anti-CD20monoclonal anti-body(rituximab)in the treatment of pemphigus. Br J Der-matol . 2005
5Cinatl .J, Morgensten B, Bauer G, et al. Glycyrrhizin, an active component of liquorice roots and replication of SARS associated coronavirus [J].Lancet ,2003,361:2046.
